SpringWorks Therapeutics · 1 day ago
Territory Business Manager - Saint Louis
SpringWorks Therapeutics is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. The Territory Business Manager will lead sales at the territory level, serve as the primary liaison between customers and the company, and be responsible for achieving revenue goals through effective communication and collaboration with the commercial team.
BiopharmaBiotechnologyTherapeutics
Responsibilities
Maintain an expert operating knowledge of all company policies and guidelines including but not limited to those addressing interactions with Healthcare Professionals, compliance and business conduct
Ensure compliance with all Company, industry and government laws or regulations including guidelines pertaining to ethical business practices
Accountable for overall territory revenue and customer support
Achieve short and long-term sales objectives by identifying customer needs and providing solutions to create a professional relationship between the customer and SpringWorks Therapeutics, a healthcare company of Merck KGaA Darmstadt Germany in both the live and virtual setting, as well as, within the community/academic setting respectfully
Build relationships with key HCP’s, physician practices, and hospitals/clinics, practice managers across various treatment and academic settings, including major cancer centers
Be a territory expert having deep market, customer, product, and competitive insights. Understand the changing healthcare landscape and strategically adapt to succeed in a constantly evolving environment
Successfully complete ongoing training and development to include product knowledge, selling skills, goal setting, planning and analysis, use of marketing tools and clinical information and sales competencies
Strategically identify and enact ways to appropriately put patients and customers first, demonstrating behaviors and prioritizing those tasks which will enable delivery of medicines to patients with greater speed and increase the ability to help patients’ lives
Demonstrate strong critical analytic and planning skills in reviewing data, understanding trends, preparing, communicating applicable plans and embracing the digital platforms/omnichannel strategies
Fully participate in field coaching sessions, including receiving guidance, positive reinforcement, and corrective action where needed with a focus on the execution of accounts plans and competency development to ensure revenue targets are met
Work collaboratively and manage ongoing communication and tactical coordination with field and HQ colleagues
Work to support local/area KOL’s
Qualification
Required
Bachelor's degree required
7+ years of pharmaceutical and/or biotech experience required
5+ years proven Rare Disease sales experience in the pharmaceutical/ healthcare industry with demonstration of successful results
Neurology experience– pediatric and adult experience
Oncology experience
Experience selling in a competitive market
Experience in Rare Disease sales
Experience with virtual selling and track record of embracing technology
Strong expertise in reimbursement and managed care knowledge
Possesses high integrity and exceptional work ethic. Fosters mutual trust and respect
Strong organizational skills
Strong communication both written and verbal
A connector and one who thinks and acts as one team
Collaborative and curious by nature
Embody the Values of SpringWorks Therapeutics, a healthcare company of Merck KGaA Darmstadt Germany to act with empathy and humility to drive a culture that takes ownership and accountability for their individual performance
A valid and active driver's license
Position may require domestic travel up to 50% of time
Candidate must live within the identified territory
Preferred
Advanced degree preferred
In-depth understanding of the Neurology/Oncology landscape and market dynamics is highly desirable
Benefits
Best-in-class benefits
Company
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Funding
Current Stage
Public CompanyTotal Funding
$1.02BKey Investors
Perceptive Advisors
2025-04-28Acquired
2023-12-04Post Ipo Equity· $275M
2022-09-07Post Ipo Equity· $225M
Recent News
2025-12-15
Company data provided by crunchbase